According to the new market research report “Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (Mass Spectrometry, Chromatography), Carbohydrates, Reagents & Chemicals), Application (Disease Diagnostics), End-User (Academic) -Global Forecasts to 2025″, published by MarketsandMarkets™, the global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%.
Browse in-depth TOC on “Glycobiology Market”
194 – Tables
29 – Figures
173 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
The growth of this market is majorly driven by the increasing research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, growth in the proteomics market. On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment. However, the high cost of tools is expected to hamper the market growth to a certain extent during the forecast period.
The companies have a large market spread across various countries in North America, Europe, Asia Pacific, and the Rest of the World.
Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Largely unknown before the outbreak began in Wuhan, China, in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a few weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020. The COVID-19 pandemic has led to major changes in the clinical operations of radiology departments worldwide. In parallel with clinical preparedness activities, academic medical centers and universities were rushed to shut down scientific research activities to maximize social distancing and minimize the spread of infection to research staff and others with whom they might have contact.
The demand for glycomics products for drug discovery & development is estimated to grow at a high rate during the forecast period
Based on application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications. Drug discovery & development is the largest and the fastest-growing application segment in the market, majorly due to the increasing R&D investments in pharmaceutical and biotechnology companies and the growing number of drug discovery research activities in academic research institutes.
Enzymes segment accounted for the largest share of the glycomics market, by product, in 2019
The market is categorized into five product segments, namely, enzymes, instruments, kits, carbohydrates, and reagents & chemicals. The enzymes segment is expected to dominate the market in 2020 and is projected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the consumable nature of enzymes and their wide applications in a variety of R&D and drug discovery procedures.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
The global glycomics market is segmented into North America (US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa). In 2020, North America is expected to dominate the global market, followed by Europe. The largest share of North America is mainly attributed to increasing investments in glycomics research, rising R&D investments in pharmaceutical companies for drug discovery and the presence of all key players.
The prominent players operating in the glycomics market include Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), and Ludger Ltd. (UK).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=132685525
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: [email protected]
Content Source: https://www.marketsandmarkets.com/PressReleases/radiopharmaceuticals.asp
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/radiopharmaceuticals-market.asp
Glycobiology products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets.
The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.According to the new market research report "Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021", published by MarketsandMarkets™, The global glycobiology market is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525Glycobiology Market DynamicsDrivers1.
Increasing funding for Proteomics & glycomics research and growingR expenditure2.
Technological advancements in glycomics instrumentationRestraints1.
Stringent regulatory frameworks and time-consuming approval processesOpportunities1.
Increased use of personalized medicine2.
The Global Glycobiology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on product, application and end-use.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Glycobiology Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/16705-glycobiology-market-reportThe report also covers the complete competitive landscape of the global Glycobiology market with company profiles of key players such as:Agilent TechnologiesBruker GroupDanaher Corp.New England BiololabsProzyme Inc.Shimadzu Corp.Sigma AldrichTakara Bio.Thermo Fisher Scientific Inc.Waters Corp.A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Product:EnzymesGlycosidasesNeuraminidasesGycotransferasesKitsGlycan Release KitsGlycan Purification KitsGlycan Labeling KitsOther KitsInstrumentsAntibody ArraysLectin ArraysHPLCMALDI-TOFMass SpectroscopyReagentsMonosaccharidesOligosaccharidesGlycoproteinsBy Applications:Drug discovery & developmentDiagnosticsOncologyImmunologyBy End-Use:Pharmaceutical & biotechnological companiesAcademic research institutesContract research organizationsBy Geography:North America (NA)Europe (EU)Asia Pacific (APAC)Latin America (LA)Middle East & Africa (MEA)Download Free Sample Report of Global Glycobiology Market @ https://www.decisiondatabases.com/contact/download-sample-16705The Global Glycobiology Market has been exhibited in detail in the following chapters –Chapter 1 Glycobiology Market PrefaceChapter 2 Executive SummaryChapter 3 Glycobiology Industry AnalysisChapter 4 Glycobiology Market Value Chain AnalysisChapter 5 Glycobiology Market Analysis By ProductChapter 6 Glycobiology Market Analysis By ApplicationsChapter 7 Glycobiology Market Analysis By End-UseChapter 8 Glycobiology Market Analysis By GeographyChapter 9 Competitive Landscape Of Glycobiology CompaniesChapter 10 Company Profiles Of Glycobiology IndustryPurchase the complete Global Glycobiology Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-16705Other Reports by DecisionDatabases.com:Global Synthetic Biology Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Microbiology Testing/Clinical Microbiology Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Molecular Biology Kits And Reagents Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
The growth of this market is majorly driven by the increasing research activities on glycomics, rising R investments in pharmaceutical and biotechnology companies, growth in the proteomics market.
On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment.
[173 Pages Report] The global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%.
This study involved four major activities in estimating the current size of the glycomics market.
Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Market DynamicsIncreasing R Expenditure and Funding for Proteomics and Glycomics ResearchGrowth of the Proteomics MarketTechnological Advancements in Glycomics InstrumentationThe market is categorized into five product segments, namely, enzymes, instruments, kits, carbohydrates, and reagents & chemicals.
